Nov 11 (Reuters) - Diagonal Bio AB DIABIO.ST :
* ANNOUNCES THAT IT IS EXPLORING FINANCING OPTIONS
* IS IN DISCUSSIONS WITH STRATEGIC INVESTORS AND SEVERAL OF
ITS
LARGER SHAREHOLDERS REGARDING POSSIBLE SOLUTIONS TO ADDRESS
COMPANY'S LIQUIDITY SITUATION
* CO HAS PLAN, AMBITION TO REACH MARKET VALIDATION WITH
LAMPLIFY
IN 2025, FUNDS NEEDED FOR THIS OBJECTIVE IS ESTIMATED TO ABOUT
SEK 7 MILLION
Source text: ID:nWkrbrf84B
Further company coverage: DIABIO.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com;))